Generation and characterization of telomerase transfected human lymphatic endothelial cells with an extended life span

被引:86
作者
Nisato, RE
Harrison, JA
Buser, R
Orci, L
Rinsch, C
Montesano, R
Dupraz, P
Pepper, MS
机构
[1] Univ Geneva, Med Ctr, Dept Morphol, CH-1211 Geneva 4, Switzerland
[2] Isotis SA, Lausanne, Switzerland
关键词
D O I
10.1016/S0002-9440(10)63271-3
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The study of lymphatic endothelial cells and lymphangiogenesis has, in the past, been hampered by the lack of lymphatic endothelial-specific markers. The recent discovery of several such markers has permitted the isolation of lymphatic endothelial cells (LECs) from human skin. However, cell numbers are limited and purity is variable with the different isolation procedures. To overcome these problems, we have transfected human dermal microvascular endothelial cells (HDMVECs) with a retrovirus containing the coding region of human telomerase reverse transcriptase (hTERT), and have produced a cell line, hTERT-HDLEC, with an extended lifespan. hTERTHDLEC exhibit a typical cobblestone morphology when grown in culture, are contact-inhibited, and express endothelial cell-specific markers. hTERTHDLEC also express the recognized lymphatic markers, Prox-1, LYVE-1 and podoplanin, as well as integrin alpha9, but do not express CD34. They also form tube-like structures in three-dimensional collagen gels when stimulated with vascular endothelial growth factors -A and -C. Based on these currently recognized criteria, these cells are LEC. Surprisingly, we also found that the widely studied HMEC-1 cell line expresses recognized lymphatic markers; however, these cells are also CD34-positive. In summary, the ectopic expression of hTERT increases the life span of LECs and does not affect their capacity to form tubelike structures in a collagen matrix. The production and characterization of hTERT-HDLEC will facilitate the study of the properties of lymphatic endothelium invitro.
引用
收藏
页码:11 / 24
页数:14
相关论文
共 50 条
[21]   LYMPHATIC ENDOTHELIUM ISOLATION, CHARACTERIZATION AND LONG-TERM CULTURE [J].
LEAK, LV ;
JONES, M .
ANATOMICAL RECORD, 1993, 236 (04) :641-652
[22]   Novel cytokine-independent induction of endothelial adhesion molecules regulated by plateletl/endothelial cell adhesion molecule (CD31) [J].
Litwin, M ;
Clark, K ;
Noack, L ;
Furze, J ;
Berndt, M ;
Albelda, S ;
Vadas, M ;
Gamble, J .
JOURNAL OF CELL BIOLOGY, 1997, 139 (01) :219-228
[23]   Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3 [J].
Mäkinen, T ;
Veikkola, T ;
Mustjoki, S ;
Karpanen, T ;
Catimel, B ;
Nice, EC ;
Wise, L ;
Mercer, A ;
Kowalski, H ;
Kerjaschki, D ;
Stacker, SA ;
Achen, MG ;
Alitalo, K .
EMBO JOURNAL, 2001, 20 (17) :4762-4773
[24]   Regulation of angiopoietin-2 mRNA levels in bovine microvascular endothelial cells by cytokines and hypoxia [J].
Mandriota, SJ ;
Pepper, MS .
CIRCULATION RESEARCH, 1998, 83 (08) :852-859
[25]  
Mandriota Stefano J., 1999, Journal de la Societe de Biologie, V193, P159
[26]   INVITRO RAPID ORGANIZATION OF ENDOTHELIAL-CELLS INTO CAPILLARY-LIKE NETWORKS IS PROMOTED BY COLLAGEN MATRICES [J].
MONTESANO, R ;
ORCI, L ;
VASSALLI, P .
JOURNAL OF CELL BIOLOGY, 1983, 97 (05) :1648-1652
[27]   TUMOR-PROMOTING PHORBOL ESTERS INDUCE ANGIOGENESIS INVITRO [J].
MONTESANO, R ;
ORCI, L .
CELL, 1985, 42 (02) :469-477
[28]   Absence of cancer-associated changes in human fibroblasts immortalized with telomerase [J].
Morales, CP ;
Holt, SE ;
Ouellette, M ;
Kaur, KJ ;
Yan, Y ;
Wilson, KS ;
White, MA ;
Wright, WE ;
Shay, JW .
NATURE GENETICS, 1999, 21 (01) :115-118
[29]   ADVANCED MAMMALIAN GENE-TRANSFER - HIGH TITER RETROVIRAL VECTORS WITH MULTIPLE-DRUG SELECTION MARKERS AND A COMPLEMENTARY HELPER-FREE PACKAGING CELL-LINE [J].
MORGENSTERN, JP ;
LAND, H .
NUCLEIC ACIDS RESEARCH, 1990, 18 (12) :3587-3596
[30]   αvβ3 and αvβ5 integrin antagonists inhibit angiogenesis in vitro [J].
Riccardo E. Nisato ;
Jean-Christophe Tille ;
Alfred Jonczyk ;
Simon L. Goodman ;
Michael S. Pepper .
Angiogenesis, 2003, 6 (2) :105-119